Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmasol is a Turkish hemodialysis products company focused on the development, manufacture, and supply of consumables and solutions used in dialysis care. Its portfolio includes dialyzers, bloodlines, bicarbonate cartridges and bags, hemodialysis solutions, disinfectants, and fistula needles designed to be compatible with widely used dialysis machines. The company operates manufacturing facilities in Kayseri, Turkey and has built its business around commercial-stage renal care products rather than a therapeutic drug pipeline. Farmasol was founded in 2005 and became part of Pollet Medical Group in January 2025, while continuing operations under the Farmasol name. The business appears best characterized as a renal medtech/manufacturing company rather than a traditional biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmasol.